Navidea生物制药(NAVB)

1.75 -0.01 -0.57%

今开:1.78昨收:1.76
最高:1.78 最低:1.71
涨停价:0.0跌停价:0.0
总市值:5.2785679E7

Navidea生物制药的最新评论

当期报告

Navidea生物制药(NAVB)10-15 04:06

$Navidea生物制药(NAVB)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001437749-21-023670 Act: 34 Size: 188 KB 网页链接查看全文

首次持股声明

Navidea生物制药(NAVB)10-06 04:06

$Navidea生物制药(NAVB)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001437749-21-023293 Size: 2 KB 网页链接查看全文

持股变动声明

Navidea生物制药(NAVB)10-02 04:06

$Navidea生物制药(NAVB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-023085 Size: 4 KB 网页链接查看全文

持股变动声明

Navidea生物制药(NAVB)10-02 04:06

$Navidea生物制药(NAVB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-023086 Size: 4 KB 网页链接查看全文

持股变动声明

Navidea生物制药(NAVB)10-02 04:06

$Navidea生物制药(NAVB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-023087 Size: 4 KB 网页链接查看全文

当期报告

Navidea生物制药(NAVB)10-01 04:06

$Navidea生物制药(NAVB)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001437749-21-022925 Act: 34 Size: 179 KB 网页链接查看全文

持股变动声明

Navidea生物制药(NAVB)09-18 04:48

$Navidea生物制药(NAVB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-022353 Size: 4 KB 网页链接查看全文

当期报告

Navidea生物制药(NAVB)09-17 20:06

$Navidea生物制药(NAVB)$ 8-K Current report, items 5.02, 5.07, and 9.01 Accession Number: 0001437749-21-022300 Act: 34 Size: 184 KB 网页链接查看全文

季度财报

Navidea生物制药(NAVB)08-13 05:12

$Navidea生物制药(NAVB)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001437749-21-019756 Act: 34 Size: 6 MB 网页链接查看全文

当期报告

Navidea生物制药(NAVB)08-12 04:27

$Navidea生物制药(NAVB)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001437749-21-019466 Act: 34 Size: 133 KB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29

Navidea生物制药的公告

$Navidea生物制药(NAVB)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001437749-20-023660 Act: 34 Size: 175 KB 网页链接

$Navidea生物制药(NAVB)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001437749-20-023028 Size: 15 KB 网页链接

$Navidea生物制药(NAVB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-20-023031 Size: 5 KB 网页链接

$Navidea生物制药(NAVB)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-20-002467 Act: 33 Size: 1 KB 网页链接

$Navidea生物制药(NAVB)$ 8-K Current report, item 5.07 Accession Number: 0001437749-20-019570 Act: 34 Size: 43 KB 网页链接

$Navidea生物制药(NAVB)$ 内部交易: 2020-08-30,10% Owner,Scott John K Jr. ,买入,5000普通股, $5.00

$Navidea生物制药(NAVB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001753763-20-000002 Size: 8 KB 网页链接

$Navidea生物制药(NAVB)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001437749-20-019241 Act: 33 Size: 564 KB 网页链接

$Navidea生物制药(NAVB)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001437749-20-019242 Act: 33 Size: 527 KB 网页链接

$Navidea生物制药(NAVB)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001193125-20-238219 Act: 34 Size: 49 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33